Probiotics and Prebiotics for Promoting Health: Through Gut Microbiota

Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion

Volumn , Issue , 2016, Pages 75-85

  Kumar, Manoj ^a   Nagpal, Ravinder ^b   Hemalatha, Rajkumar ^a   Yadav, Hariom ^c   Marotta, Francesco ^d  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d ReGenera Research Group for Aging Intervention   (Italy)

Author keywords

Bifidobacterium; Gut microbiota; Gut microflora; Lactobacillus; Metabolic syndrome; Obesity; Prebiotics; Probiotics; Synbiotic; Type 2 diabetes

Indexed keywords

EID: 84966738296     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802189-7.00006-X     Document Type: Chapter

References (113)

1. Abrahamsson T.R., Jakobsson T., Böttcher M.F., Fredrikson M., Jenmalm M.C., Björksten B., Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119:1174-1180.
2. Alles M.S., Hartemink R., Meyboom S., Harryman J.L., Van Laere K.M.J., Nagengast F.M., Hautvast J.G.A.J. Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on the putative risk markers for colon cancer. Am. J. Clin. Nutr. 1999, 69:980-991.
3. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
4. Arumugam M., Raes J., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
5. Azaıs-Braesco V., Bresson J.L., Guarner F., Corthier G. Not all lactic acid bacteria are probiotics, but some are. Br. J. Nutr. 2010, 103:1079-1081.
6. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15718-15723.
7. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
8. Bergman E.N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 1990, 70:567-590.
9. Bernardo W.M., Aires F.T., Carneiro R.M., Sa F.P., Rullo V.E., Burns D.A. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J. Pediatr. 2013, 89:18-24.
10. Boleij A., Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. Camb. Philos. Soc. 2012, 87:701-730.
11. Booijink C.C., Zoetendal E.G., Kleerebezem M., de Vos W.M. Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol. 2007, 2:285-295.
12. Bravo J., Forsythe P., Chew M., Escaravage E., Savignac H., Dinan T., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16050-16055.
13. Bron P., Van Baarlen P., Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol. 2011, 10:66-78.
14. Canani R.B., Cirillo P., Terrin G., Cesarano L., Spagnuolo M.I., De Vincenzo A., Albano F., Passariello A., De Marco G., Manguso F., Guarino A. Probiotics for treatment of acute diarrhea in children: randomised clinical trial of five different preparations. Br. Med. J. 2007, 335:340.
15. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmée E., Cousin B., Sulpice T., Chamontin B., Ferrières J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
16. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
17. Chmielewska A., Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J. Gastroenterol. 2010, 16:69-75.
18. Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.S., Myung S.J. A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J. Clin. Gastroenterol. 2011, 45:679-683.
19. Cox M., Huang Y., Fujimura K., Liu J., McKean M., Boushey H., Segal M.R., Brodie E.L., Cabana M.D., Lynch S.V. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One 2010, 5:e8745.
20. Cruywagen C.W., Jordan I., Venter L. Effect of Lactobacillus acidophilus supplementation of milk replacer on preweaning performance of calves. J. Dairy Sci. 1995, 79:483-486.
21. Czarnecki-Maulden G. Using probiotics to optimize intestinal health. Vet. Tech. 2008, 29:610.
22. Davis L.M., Martinez I., Walter J., Goin C., Hutkins R.W. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011, 6:e25200.
23. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4554-4561.
24. Dominguez-Bello M.G., Blaser M.J., Ley R.E., Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011, 140:1713-1719.
25. Donohue D.C., Salminen S. Safety of probiotic bacteria. Asia Pac. J. Clin. Nutr. 1996, 5:25-28.
26. Doron S.I., Hibberd P.L., Gorbach S.L. Probiotics for prevention of antibiotic-associated diarrhea. J. Clin. Gastroenterol. 2008, 42:S58-S63.
27. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
28. FAO Food and Agriculture Organization of the United Nations. Guidelines for the evaluation of probiotics in foods 2009, ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
29. Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int. J. Environ. Res. Public Health 2014, 11:4745-4767.
30. Fitzpatrick L.R. Probiotics for the treatment of Clostridium difficile associated disease. World J. Gastroint. Pathophysiol. 2013, 4:47-52.
31. Flint H.J., Bayer E.A., Rincon M.T., Lamed R., White B.A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 2008, 6:121-131.
32. Forno E., Onderdonk A., McCracken J., Litonjua A., Laskey D., Delaney M.L., Dubois A.M., Gold D.R., Ryan L.M., Weiss S.T., Celedón J.C. Diversity of the gut microbiota and eczema in early life. Clin. Mol. Allergy 2008, 6:11.
33. Fox S.M. Probiotics intestinal inoculants for production animals. Vet. Med. 1988, 83:806-830.
34. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989, 66:365-378.
35. Fuller R. What is a probiotic?. Biologist 2004, 51:232.
36. Gibson G.R. Dietary modulation of the human gut microflora using prebiotics. Br. J. Nutr. 1998, 80:S209-S212.
37. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concepts of prebiotics. J. Nutr. 1995, 125:1401-1412.
38. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17:259-275.
39. Guarner F., Schaafsma G.J. Probiotics. Int. J. Food Microbiol. 1998, 39:237-238.
40. Havenaar R., Huis in't Veld J.H.J. Probiotics: a general view. The Lactic Acid Bacteria in Health and Disease 1992, 209-224. Elsevier Applied Science, London. B. Wood (Ed.).
41. Hemalatha R., Kumar M., Das N., Kumar N.S., Challa H.R., Nagpal R. Effect of probiotic Lactobacillus salivarius UBLS22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 2014, 20(3):289-298. [Epub ahead of print]. 10.1177/1074248414555004.
42. Hemarajata P., Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther. Adv. Gastroenterol. 2013, 6:39-51.
43. Hemsworth J.C., Hekmat S., Reid G. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 2012, 3:414-419.
44. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., Calder P.C., Sanders M.E. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11(8):506-514. [Epub ahead of print]. 10.1038/nrgastro.2014.66.
45. Isolauri E., Rautava S., Kalliomaki M. Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002, 2:263-271.
46. Jarchum I., Pamer E. Regulation of innate and adaptive immunity by the commensal microbiota. Curr. Opin. Immunol. 2011, 23:353-360.
47. Jernberg C., Löfmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
48. Johnston B.C., Goldenberg J.Z., Vandvik P.O., Sun X., Guyatt G.H. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2011, 11:CD004827. 10.1002/14651858.CD004827.pub2.
49. Joossens M., Huys G., Van Steen K., Cnockaert M., Vermeire S., Rutgeerts P., Verbeke K., Vandamme P., De Preter V. High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol. Ecol. 2011, 75:343-349.
50. Kajander K., Myllyluoma E., Rajilic-Stojanovic M., Kyrönpalo S., Rasmussen M., Järvenpää S., Zoetendal E.G., de Vos W.M., Vapaatalo H., Korpela R. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment. Pharmacol. Ther. 2008, 27:48-57.
51. Ki Cha B., Mun Jung S., Hwan Choi C., Song I., Woong Lee H., Joon Kim H., Hyuk J., Kyung Chang S., Kim K., Chung W.S., Seo J.G. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J. Clin. Gastroenterol. 2011, 46:220-227.
52. Kmet V., Flint H.J., Wallace R.J. Probiotics and manipulation of rumen development and function. Arch. Anim. Nutr. 1993, 44:1-10.
53. 1-induced hepatocellular carcinoma. Gene 2011, 490:54-59.
54. 1 induced liver carcinogenesis in rats. Br. J. Nutr. 2012, 107:1006-1016.
55. Kumar M., Rakesh S., Nagpal R., Kumar R., Hemalatha R., Ramakrishna A., Sudarshan V., Ramagoni R., Shujauddin M., Verma V., Kumar A., Tiwari A., Singh B. Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improves lipid profiles in hypercholesterolemic rats. Nutrition 2013, 29:574-579.
56. Langlands S.J., Hopkins M.J., Coleman N., Cummings J.H. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004, 53:1610-1616.
57. Lay C., Rigottier-Gois L., Holmstrom K., Rajilic M., Vaughan E.E., de Vos W.M., Collins M.D., Thiel R., Namsolleck P., Blaut M., Dore J. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 2005, 71:4153-4155.
58. Lee B., Bak Y. Irritable bowel syndrome, gut microbiota and probiotics. J. Neurogastroenterol. Motil. 2011, 17:252-266.
59. Lee S.J., Bose S., Seo J.G., Chung W.S., Lim C.Y., Kim H. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial. Clin. Nutr. 2013, 33(6):973-981. 10.1016/j.clnu.2013.12.006.
60. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11070-11075.
61. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
62. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
63. Lilly D.M., Stillwell R.H. Probiotics: growth promoting factors produced by microorganisms. Science 1965, 147:747-748.
64. Liu Y., Fatheree N., Mangalat N., Rhoads J. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G1087-G1096.
65. Macfarlane G.T., Cummings J.H. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?. Br. Med. J. 1999, 318:999-1003.
66. Macfarlane G.T., Steeds H., Macfarlane S. Bacterial metabolism and health related effects of galactooligosaccharides and other prebiotics. J. Appl. Microbiol. 2008, 104:305-344.
67. Mayer E. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12:453-466.
68. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 2007, 5:97-105.
69. Metchnikoff E. The Prolongation of Life 1908, G.P. Putnam's Sons, New York. first ed.
70. Mohania D., Kansal V.K., Shah D., Kumar M., Gautam S.K., Singh B., Behare P.V., Nagpal R. Therapeutic effect of probiotic Dahi (yogurt) on plasma, aortic and hepatic lipid profile of hypercholesterolemic rats. J. Cardiovasc. Pharmacol. Ther. 2013, 18:490-497.
71. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., Cresci A., Silvi S., Orpianesi C., Verdenelli M.C., Clavel T., Koebnick C., Zunft H.J., Doré J., Blaut M. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 2006, 72:1027-1033.
72. Nagalingam N.A., Lynch S.V. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 2012, 18:968-984.
73. Nagpal R., Kumar A., Kumar M., Behare P.V., Jain S., Yadav H. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol. Lett. 2012, 334:1-15.
74. Naidu A.S., Bidlack W.R., Clemens R.A. Probiotic spectra of lactic acid bacteria (LAB). Crit. Rev. Food Sci. Nutr. 1999, 39:13-126.
75. Neufeld K., Foster J. Effects of gut microbiota on the brain: implications for psychiatry. J. Psychiatry Neurosci. 2009, 34:230-231.
76. Nobaek S., Johansson M., Molin G., Ahrne S., Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol. 2000, 95:1231-1238.
77. O'Shea E., Cotter P., Stanton C., Ross R., Hill C. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int. J. Food Microbiol. 2011, 152:189-205.
78. Orlando A., Russo F. Intestinal microbiota, probiotics and human gastrointestinal cancers. J. Gastrointest. Cancer 2013, 44:121-131.
79. Parker R.B. Probiotics: the other half of the antibiotic story. Anim. Nutr. Health 1974, 29:4-8.
80. Preidis G., Saulnier D., Blutt S., Mistretta T., Riehle K., Major A., Venable S.F., Finegold M.J., Petrosino J.F., Conner M.E., Versalovic J. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J. 2012, 26:1960-1969.
81. Qin H.L., Zheng J.J., Tong D.N., Chen W.X., Fan X.B., Hang X.M., Jiang Y.Q. Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur. J. Clin. Nutr. 2008, 62:923-930.
82. Qin J., Li R., Raes J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
83. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
84. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101:541-550.
85. Rastall R.A. Bacteria in the gut: friends and foes and how to alter the balance. J. Nutr. 2004, 134:2022S-2026S.
86. Rastall R.A., Maitin V. Prebiotics and synbiotics: towards the next generation. Curr. Opin. Biotechnol. 2002, 13:490-496.
87. Rinne M.M., Gueimonde M., Kalliomäki M., Hoppu U., Salminen S.J., Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol. Med. Microbiol. 2005, 43:59-65.
88. Roselli M., Finamore A., Britti M., Bosi P., Oswald I., Mengheri E. Alternatives to in-feed antibiotics in pig production: evaluation of probiotics, zinc oxide or organic acids as protective agents for the intestinal mucosa: a comparison of in vitro and in vivo results. Anim. Res. 2005, 54:203-218.
89. Salminen S. Uniqueness of probiotic strains. IDF Nutr. Newsl. 1996, 5:16-18.
90. Salminen S., Ouwehand A., Benno Y., Lee Y.K. Probiotics: how should they be defined?. Trends Food Sci. Technol. 1999, 10:107-110.
91. Salminen S., Gibson G.R., McCartney A.L., Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004, 53:1388-1389.
92. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
93. Schrezenmeir J., de Vrese M. Probiotics, prebiotics, and synbiotics: approaching a definition. Am. J. Clin. Nutr. 2001, 73:361S-364S.
94. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., Hardt P.D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18:190-195.
95. Serban D.E. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 2013, 345:258-270.
96. Sperti G.S. Probiotics 1971, AVI Publishing Co., West Point, CT.
97. Stephen A.M., Cummings J.H. Mechanism of action of dietary fibre in the human colon. Nature 1980, 284:283-284.
98. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., Harmsen H., Welling G. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl. Environ. Microbiol. 2004, 70:2129-2136.
99. Tap J., Mondot S., Levenez F., Pelletier E., Caron C., Furet J.P., Ugarte E., Munoz-Tamayo R., Paslier D.L., Nalin R., Dore J., Leclerc M. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 2009, 11:2574-2584.
100. The Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
101. Thomas C., Hong T., Van Pijkeren J., Hemarajata P., Trinh D., Hu W., Britton R.A., Kalkum M., Versalovic J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of Pka and Erk signaling. PLoS One 2012, 7:e31951.
102. Todd R.K. The probiotic concept. Food Microbiology, Fundamental and Frontiers 2001, 128-139. ASM Press, Washington, DC, USA. second ed. P.D. Michael, R.B. Larry, J.M. Thomas (Eds.).
103. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., Gordon J.I. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
104. Wallace T.C., Guarner F., Madsen K., Cabana M.D., Gibson G., Hentges E., Sanders M.E. Human gut microbiota and its relationship to health and disease. Nutr. Rev. 2011, 69:392-403.
105. Walter J., Britton R.A., Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4645-4652.
106. Walton G.E., van den Heuvel E.G., Kosters M.H., Rastall R.A., Tuohy K.M., Gibson G.R. A randomised crossover study investigating the effects of galactooligosaccharides on the faecal microbiota in men and women over 50 years of age. Br. J. Nutr. 2012, 107:1466-1475.
107. Whitman W.B., Coleman D.C., Wiebe W.J. Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6578-6583.
108. Wilhelm S.M., Johnson J.L., Kale-Pradhan P.B. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. Ann. Pharmacother. 2011, 45:960-966.
109. Woodmansey E.J. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007, 102:1178-1186.
110. Wostmann B.S., Larkin C., Moriarty A., Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 1983, 33:46-50.
111. Yadav H., Jain S., Sinha P.R. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007, 23:62-68.
112. Yadav H., Lee J.H., Lloyd J., Walter P., Rane S.G. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J. Biol. Chem. 2013, 288:25088-25097.
113. Zelaya H., Tsukida K., Chiba E., Marranzino G., Alvarez S., Kitazawa H., Agüero G., Villena J. Immunobiotic Lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation-coagulation interactions. Int. Immunopharmacol. 2014, 19:161-173.